Helicos Raises $6.4M
Luke Timmerman12/16/09
Helicos Biosciences, the Cambridge, MA-based maker of genetic research instruments, said today it has raised $6.4 million. The company (NASDAQ: HLCS) collected the cash by offering a combination stock and warrants. The deal was underwritten by Thomas Weisel Partners.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
